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During embryonic and postnatal skeletal development, the shape and length of bones is determined by the activities 
of the growth plate cartilage. Growth plate cartilage promotes 
elongation of long bones via regulation of chondrocyte matura­
tion that is reflected in morphologically and functionally unique 
cellular domains.1 Toward the distal (epiphyseal) end resides the 
resting (or reserve) zone that is composed of the least mature 
chondrocytes.2 These resting zone chondrocytes are progres­
sively recruited into the proliferative zone, where cell cycle ac­
tivation and changes in cell morphology and cell organization 
result in expansion of isogenic columns of chondrocytes along 
the axis of growth.3 
As columns lengthen, chondrocytes at the proximal (meta­
physeal) end of the column withdraw from the cell cycle and 
increase in volume (hypertrophy) in two steps that are char­
acteristic of the prehypertrophic and the hypertrophic chon­
drocytes.4,5 Growth is generated from chondrocyte hypertrophy 
through increased cell mass and deposition of specialized ma­
trix.6 Hypertrophic chondrocytes are subsequently replaced by 
bone through the process of endochondral ossification.7 Thus, 
continuous growth over the two­decade span of human devel­
opment requires tight coordination between cell production in 
the resting and proliferative zones, and cartilage loss in the hy­
pertrophic zone. 
Chondrocyte maturation in growth plate cartilage is coordi­
nated by a complex paracrine signaling network that is rooted 
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Abstract 
Defining the final size and geometry of engineered tissues through precise control of the scalar and vector components of tissue 
growth is a necessary benchmark for regenerative medicine, but it has proved to be a significant challenge for tissue engineers. The 
growth plate cartilage that promotes elongation of the long bones is a good model system for studying morphogenetic mechanisms 
because cartilage is composed of a single cell type, the chondrocyte; chondrocytes are readily maintained in culture; and growth 
trajectory is predominately in a single vector. In this cartilage, growth is generated via a differentiation program that is spatially and 
temporally regulated by an interconnected network composed of long­ and short­range signaling mechanisms that together result 
in the formation of functionally distinct cellular zones. To facilitate investigation of the mechanisms underlying anisotropic growth, 
we developed an in vitro model of the growth plate cartilage by using neonatal mouse growth plate chondrocytes encapsulated in 
alginate hydrogel beads. In bead cultures, encapsulated chondrocytes showed high viability, cartilage matrix deposition, low levels 
of chondrocyte hypertrophy, and a progressive increase in cell proliferation over 7 days in culture. Exogenous factors were used to 
test functionality of the parathyroid­related protein–Indian hedgehog (PTHrP­IHH) signaling interaction, which is a crucial feedback 
loop for regulation of growth. Consistent with in vivo observations, exogenous PTHrP stimulated cell proliferation and inhibited hy­
pertrophy, whereas IHH signaling stimulated chondrocyte hypertrophy. Importantly, the treatment of alginate bead cultures with IHH 
or thyroxine resulted in formation of a discrete domain of hypertrophic cells that mimics tissue architecture of native growth plate 
cartilage. Together, these studies are the first demonstration of a tunable in vitro system to model the signaling network interactions 
that are required to induce zonal architecture in growth plate chondrocytes, which could also potentially be used to grow cartilage 
cultures of specific geometries to meet personalized patient needs. 
Keywords: growth plate cartilage, IHH/PTHrP signaling, 3D culture model, tissue architecture, alginate hydrogel Introduction 
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in reciprocal interactions between two major signal transduc­
tion pathways that include the secreted ligands PTHrP (encoded 
by Pthlh), produced by periarticular resting chondrocytes, and 
Indian hedgehog (IHH), produced by prehypertrophic chon­
drocytes.8–11 In this context, PTHrP acts to maintain resting 
chondrocytes, and it stimulates the formation of proliferative 
chondrocytes.9–12 In addition, PTHrP signaling represses hyper­
trophy, in part, through the inhibition of IHH signal transduc­
tion.12–17 Conversely, IHH induces hypertrophic differentiation in 
a PTHrP­independent manner while promoting Pthlh expression 
in periarticular resting chondrocytes.8,10,18–20 Therefore, crosstalk 
between PTHrP and IHH paracrine signaling forms the core of a 
feedback circuit that maintains long­term growth by balancing 
chondrocyte production with chondrocyte loss through endo­
chondral ossification.2,5 
Despite a deep understanding of the regulatory pathways 
that regulate growth, few options exist for clinical intervention 
in growth disorders.21–24 In vitro models of growth plate car­
tilage that reveal the network structure of regulatory interac­
tions would advance both drug discovery efforts and tissue en­
gineering solutions for growth disorders. One challenge is that 
chondrocytes readily form cartilage in vitro, but they do not 
spontaneously assemble into functional growth plates.25–28 Re­
sults using pellet cultures generated from postnatal growth plate 
chondrocytes suggest that a growth plate­like structure can be 
induced by the addition of exogenous factors. For example, pel­
let cultures treated with the hormone thyroxine or the signal­
ing molecule Wnt5a form rudimentary chondrocyte columns 
and regionally display morphological evidence of chondrocyte 
hypertrophy.29,30 
Although these observations suggest that chondrocytes re­
spond appropriately to growth factor stimulation in vitro and 
that isolated chondrocytes are competent to organize into col­
umns, these studies did not confirm formation of definitive 
growth plate structure through gene expression or demon­
strate that columns formed via known cell biological mecha­
nisms. Therefore, it remains to be determined whether a limited 
repertoire of signaling molecules is sufficient to establish growth 
plate structure in vitro. Furthermore, pellet cultures significantly 
limit mechanistic studies by affording minimal control over the 
spatial distribution of growth factors and matrix structure. A cul­
ture system that allows precise spatial and/or temporal manip­
ulation of the cellular microenvironment is needed to finely dis­
sect the molecular mechanisms that regulate vertebrate growth. 
To establish an in vitro model of growth plate cartilage, we 
encapsulated primary growth plate chondrocytes in beads com­
posed of alginate hydrogel. Alginate is a linear polysaccharide 
that forms hydrogels when crosslinked in the presence of diva­
lent cations.31 It is widely used in tissue engineering applications 
because of its inherent nonfouling nature and ease of function­
alization of the alginate molecule, and because the pore size 
of alginate hydrogels allows for the diffusion of waste out and 
nutrients and growth factors into the tissue­engineered con­
struct.31–40 Growth plate chondrocytes that have been encap­
sulated in ‘‘semi­solid’’ alginate beads maintain a rounded mor­
phology.31–33 More recently, groups have utilized alginate to 
inject growth plate chondrocytes into mice for long­term cul­
ture, and they have even observed zonal arrangement and col­
umn formation.40,41 However, due to the complex nature of the 
in vivo culture environment, the crucial factors for growth plate 
development were not elucidated. 
In the current study, we describe a novel three­dimensional 
(3D) in vitro culture model where chondrocytes encapsulated 
within alginate hydrogel scaffolds display zonal arrangement 
of gene expression domains consistent with growth plate car­
tilage architecture. In our culture system, chondrocytes display 
cell cycle properties and generate extracellular matrix consis­
tent with growth plate chondrocytes. Moreover, we show that 
chondrocyte hypertrophy can be regulated by exogenous ma­
nipulation of PTHrP and IHH signaling. Importantly, treatment 
of alginate bead cultures with soluble IHH protein or thyrox­
ine induces formation of a spatially distinct zone of hypertro­
phy. Our results indicate that we have recapitulated the PTHrP/
IHH feedback loop in a minimal culture system and, thus, have 
developed a viable model for studies of the genetic regulatory 
network that maintains the growth plate cartilage, thereby pro­
moting bone growth. 
Materials and Methods 
Materials 
Unless otherwise indicated, chemicals and reagents were ob­
tained from Sigma Aldrich (St. Louis, MO), EMD (Darmstadt, Ger­
many), or Thermo Fisher Scientific (Waltham, MA); cell culture 
media from Gibco/Life Technologies (Grand Island, NY); oligonu­
cleotides from IDT (Coralville, IA); and consumables from Thermo 
Fisher Scientific or VWR (Radnor, PA). Growth factors were ob­
tained from Sigma­Aldrich, EMD Calbiochem (San Diego, CA), 
Tocris (Ellisville, MO), or R&D Systems, Inc. (Minneapolis, MN). 
Chondrocyte isolation 
Neonatal Swiss Webster mice ( Jackson Laboratories, Bar Harbor, 
ME) at postnatal day 4 (P4, with P0 being the day of birth) were 
euthanized, and the growth plate cartilage from both hind limbs 
was harvested into Hank’s balanced salt solution. Cartilage was 
transferred into complete medium that was composed of Dul­
becco’s modified Eagle medium containing 10% fetal bovine se­
rum (Atlanta Biologicals, Flowery Branch, GA) and 1% glutamine-
penicillin-streptomycin. Collagenase was added to 0.25% (w/v), 
and the cartilage was digested for 4 h in a passively humidified 
incubator at 37°C and 8% CO2
 and pipetted several times to 
break up remaining tissue. Chondrocytes were pelleted by cen­
trifugation at 125 g for 5 min by using a Sorvall Legend RT cen­
trifuge (Kendro Laboratories, Newtown CT) and resuspended in 
Complete Medium. Cell density was quantified by using a he­
mocytometer. Chondrocytes were maintained in the incubator 
until time for alginate encapsulation. All procedures performed 
on animals were consistent with regulatory agency policies and 
were approved by the Institutional Care and Use Committee at 
the University of Nebraska Medical Center. 
Chondrocyte encapsulation in alginate 
Sodium alginate powder (Pronova UP MVG, >60% guluronic 
acid, 200,000–300,000 g/mol; NovaMatrix, Sandvika, Norway) 
was dissolved in sterile phosphate-buffered saline (PBS) to a 
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concentration of 1.5% (w/v), and the solution was filtered steril­
ized by using 0.20 μm Rapid-Flow PES filters. Growth plate chon­
drocytes were pelleted by centrifugation at 125 g for 5 min and 
resuspended in an appropriate volume of alginate solution (to 8 
× 106 cells/mL) by gentle pipetting and vortexing. Homogenous 
alginate beads were formed by using the basic ‘‘drop’’ method 
previously described.34 Briefly, 10 μL of alginate-cell solution was 
drawn into a pipette tip, and the tip was wiped with a Kim­
wipe® to ensure the alginate could drop freely from the tip. The 
plunger was rapidly depressed to release a drop of the cell sus­
pension into 2mL of crosslinking solution (50mM CaCl2/140mM 
NaCl at 37°C) contained in a 24­well tissue culture dish from a 
height of 2–3 inches. Only one bead was prepared in an individ­
ual well. After 2 min of crosslinking, beads were transferred to 
a well containing 2­mL of Complete Medium for a maximum of 
10 min and then washed in minimum essential medium (MEM)­
alpha medium without Phenol Red (a­MEM) for a maximum of 
10 min. After both washes, the bead was placed into cartilage 
culture media (described later). 
Culture conditions 
Cartilage culture media were prepared by using previously de­
scribed methods4: a-MEM supplemented with 50 μL/mL GPS, 
β-glycerophosphate (10 mM), and L(+) ascorbic acid (50 μg/mL). 
In addition, dexamethasone (1 nM), proline (1 mg/mL), 1% an­
tioxidant (Sigma Aldrich), sodium pyruvate (1 mM), 1% nones­
sential amino acids (Gibco), and 1% Insulin-Transferrin-Selenium 
+3 media supplement (ITS +3; Sigma Aldrich) were added. In 
some cultures, parathyroid hormone 1–34 (PTH1–34), IHH, pur­
morphamine (PMA), bone morphogenetic protein­4 (BMP4), or 
thyroxine (T4) was added to the media at the concentrations in­
dicated in the text. Beads were cultured in a 48­well plate in a 
humidified incubator at 37°C and 8% CO2 for a maximum of 7 
days, with medium changes every day. 
Evaluation of viability 
Viability of encapsulated chondrocytes was determined by us­
ing a Live/Dead Cell Viability kit (Invitrogen). Briefly, after culture, 
beads were incubated in PBS containing 2 μM Calcein AM/4 μM 
ethidium homodimer­1 for 30 min in the dark, washed in sev­
eral changes of PBS and the fluorescence signal of live (green) 
and dead (red) cells was imaged by using a Leica DMI6000B in­
verted microscope. Live and dead cell counts were quantified 
from the resulting images by using a basic ImageJ macro (see 
Supplementary Data in appendix) to calculate percent viability. 
Immunofluorescence imaging 
For immunofluorescence analysis, all reagent and wash solutions 
contained 2mM CaCl2 to maintain crosslinking of alginate. Beads 
were fixed with 4% paraformaldehyde (PFA) for 20 min, permea­
bilized with TBST (0.1% Triton X-100/ 15-mM Tris-HCl/136-mM 
NaCl, pH 7.6), and blocked for 2 h with 10% heat-inactivated 
sheep serum (HISS; Sigma Aldrich) in TBST. Subsequently, the 
beads were incubated with gentle rocking at 4°C in either rabbit­
anti-Collagen VI (1:500; Abcam, Cambridge, United Kingdom) or 
rabbit-anti-Collagen IV (1:500; Abcam) primary antibody in 2% 
HISS/ TBST overnight. The beads were then incubated in a sec­
ondary anti­mouse AlexaFluor 647 antibody (1:1000; Jackson 
Laboratories) and phalloidin­labeled AlexaFluor 488 (1:100; In­
vitrogen) for 2 h in 2% HISS/TBST. After washing for 3 · 5 min in 
TBST, the beads were mounted with Prolong Gold antifade re­
agent with DAPI (Invitrogen) on a glass microscope slide with a 
coverslip. Images were obtained on a Leica DMI6000B inverted 
microscope or a Zeiss 710 laser scanning confocal microscope. 
For confocal microscopy, optical sections were collected at 1.8­
μm intervals for between 15 and 25 sections (total depth of 30–
40-μm), with line averaging = 2, scan speed = 4 or 5, and reso­
lution = 1024 · 1024). 
Transcript expression analysis 
For each experimental condition, four beads were depolymerized 
in 50 μL of 50 mM ethylenediaminetetraacetic acid disodium salt 
dihydrate (EDTA) and chondrocytes were recovered by centrif­
ugation. RNA was isolated from cells by using the NucleoSpin® 
RNA Plus kit (Thermo Fisher) according to the manufacturer’s 
instructions and quantified by using a Thermo Fisher Scientific 
NanoDropOne spectrophotometer. cDNA was synthesized by 
using Superscript IV (Thermo Fisher) according to the manufac­
turer’s instructions and analyzed by a digital droplet polymerase 
chain reaction (ddPCR; Bio­Rad Laboratories, Inc., Pleasanton 
CA). Thermal cycling conditions were 95°C for 5 min, 40 amplifi­
cation cycles (95°C for 30 s and 60°C for 30 s), and a final signal 
stabilization step (4°C for 5 min, 90°C for 5 min). The transcript 
count of each gene of interest was normalized with a geometric 
average of transcript counts of three normalization control tran­
scripts: actin, RPL13a, and HPRT. Data from this analysis are re­
ported as fold change in the geometric mean ± standard error 
of mean (SEM) over the transcript count of the nontreated con­
trol, and significance was calculated by using two-way analysis 
of variance (ANOVA) analysis using Prism software (GraphPad 
Software, Inc., La Jolla, CA). A full list of primer sequences and 
gene accession numbers used to generate primers is included 
in Supplementary Table S1.42–48 
Flow cytometry 
Fluorescence­activated cell sorting (FACS) was used to analyze 
cell cycle progression in cultured chondrocytes. Alginate beads 
were dissociated in 200 μL of 50mM EDTA for 5 min. Cells were 
washed with PBS and centrifuged at 125 g for 5 min. The cell 
pellet was resuspended in 200-μL of PBS and fixed by adding 
2.8mL of ice-cold 90% ethanol dropwise while vortexing. Fixed 
cells were stored at –20°C for a maximum of 7 days. For cell cycle 
analysis, DNA in fixed cells was stained with 0.05 mg/mL of prop­
idium iodide in Telford’s reagent (33.62 μg/mL EDTA, 26.8 μg/mL 
RNAse A at 93 U/mg, and 0.1% Triton X-100) for 1 h at 4°C in the 
dark. Labeled suspensions of cells were filtered through 5-mL fil­
ter­cap polypropylene Falcon tubes (Corning Labs, Tamaulipas, 
Mexico) and were then immediately analyzed on a BD FACSCal­
iber 2 flow cytometer (BD, Franklin Lakes, NJ). The resulting cell 
cycle data were represented as stacked bar graphs of the geo­
metric mean ± SEM of percentage of cells in each phase of the 
cell cycle, and significance was calculated by using a two-way 
ANOVA using GraphPad Prism software.  
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In situ hybridization 
For fluorescence in situ hybridization (FISH) analysis of gene ex­
pression in cell cultures, whole alginate beads containing chon­
drocytes were fixed in 4% PFA in TBS containing 5mM CaCl2
 
overnight at 4°C. To maintain structural integrity of the sample, 
beads were infiltrated with 37.5:1 40% acrylamide (JT Baker, Cen­
ter Valley, PA) overnight at 4°C and the acrylamide was polymer­
ized by using 10% ammonium persulfate (10 μL/mL acrylamide) 
and TEMED (1 μL/mL acrylamide). Polymerized samples were 
subsequently incubated in 30% sucrose overnight at 4°C before 
embedding in Tissue­Tek Optimum Cutting Temperature em­
bedding medium and freezing on dry ice. Sections (60 μm) were 
collected on glass microscope slides, and FISH was performed 
by using fluorescein-labeled RNA probes for collagen2a1 (ColII) 
and collagen 10a1 (ColX), as previously described.49 Slides were 
mounted by using Prolong Gold antifade reagent with DAPI (Life 
Technologies), and images were obtained on a Leica DMI6000B 
inverted microscope. The images presented in this article are 
montages that were assembled by tiling and stitching images 
from several optical planes as a z-stack (10-μm width between 
individual slices in the z­stack, 3 total slices per z­stack, total 
width of the z-stack equaling 20 μm) to visualize the entire sec­
tion of the bead for downstream quantification. To quantify cell 
counts, we used a batch processing analysis in Image J using 
a macro-programmed in-house using FIJI software (http://fiji.
sc/) to quantify the number of cells expressing the respective 
gene (for macro, see Supplementary Data). Typically, each image 
yielded cell counts of ~1000 and the data for each experimen­
tal condition were derived from ~10,000 cell counts. The frac­
tion of cells expressing a given gene was determined by divid­
ing the number of cells expressing the gene by the number of 
DAPI­positive nuclei observed in the section. The ColX:ColII ratio 
was calculated as the geometric mean of the ColX:DAPI ratio for 
each replicate divided by the geometric mean of the Col2:DAPI 
ratio for each replicate (n = 3 or 4 sections for each replicate). 
The ratio is reported as the geometric mean of the ColX:ColII ra­
tio for each replicate ± SEM. To determine statistical significance, 
a Student’s t­test was used. To determine whether a given treat­
ment had significant overall effects on hypertrophy, datasets 
from different time points were pooled into treated or untreated 
groups and compared by using a paired Wilcox signed­rank test. 
Results 
Alginate culture maintains the growth plate cartilage 
phenotype 
The objective of this study was to investigate the use of algi­
nate hydrogels as 3D scaffolds for the development of an in vitro 
growth plate model. As a starting point, we analyzed the short­
term cellular response of mouse chondrocytes to encapsulation 
within 1.5% alginate hydrogels for a maximum of 7 days. The cul­
ture conditions used resulted in cell viability greater than 90% on 
days 0, 1, 4, and 7 (Fig. 1A and Supplementary Table S2). Individ­
ual chondrocytes progressively elaborated a pericellular matrix, 
as evidenced by extracellular domains of collagen IV and colla­
gen VI, during the 7-day culture period (Fig. 1B). Since sponta­
neous dedifferentiation and hypertrophy are common problems 
in chondrocyte cultures, we next assessed chondrocyte differen­
tiation via quantitative ddPCR analysis of gene expression. Chon­
drocytes in our alginate bead cultures express high levels of ColII 
(Fig. 2A), low levels of the fibroblast marker collagen1a1 (ColI, 
Fig. 1. Culture in alginate hydrogel 
promotes chondrocyte growth. 
(A) Invitrogen Live/Dead assay to 
determine chondrocyte viability for 
at least a week of alginate culture. 
Evident cell proliferation is noticed 
over time, but low amounts of dead 
cells are seen at all time points (n 
= 3). (B) Immunofluorescence assay 
demonstrating the formation of 
pericellular matrix in alginate culture 
using antibodies against Collagen IV 
(left) and Collagen VI (right). Freshly 
isolated chondrocytes lack ECM 
staining, but they produce de novo ECM 
after 1 day in alginate culture. On day 
4 (right), a secondary ECM structure is 
observed resembling territorial matrices 
(n = 4). Arrowheads in (B) indicate the 
position of the cell membrane. Scale 
bar is 150 μm in (A) and 10 μm in (B).  
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Fig. 2B), and maintain a stable ratio of ColII:ColI gene expression 
(Fig. 2C), a measure commonly used to assess chondrocyte de­
differentiation. Although the ColII:ColI ratio did not significantly 
change over time, ColX expression, a marker of chondrocyte hy­
pertrophy, decreased rapidly and significantly (Fig. 2D). 
We also noted that cell density within the beads increased 
over time (Fig. 1A) and many of the initial single cells become 
doublets in our cultures (data not shown), two observations that 
are consistent with cell proliferation. Therefore, we performed 
cell cycle analysis of our cultures by using flow cytometry (FACS). 
FACS analysis revealed two populations of chondrocytes in our 
cultures that were distinguished by both forward and side scat­
ter measures of cell size, and, thus, will be referred to as ‘‘larger’’ 
and ‘‘smaller’’ chondrocyte populations (Supplementary Fig. S1). 
Smaller chondrocytes constituted less than 10% of the chondro­
cytes recovered from the beads and were associated with the 
only observable instances of sub­G1 peaks. In related experi­
ments, we have observed that these small cells remain in the 
G1 phase of the cell cycle regardless of condition or treatment 
(data not shown), whereas larger cells are growth factor respon­
sive (see below). Thus, only the larger, growth factor­responsive 
cells were included in the reported cell cycle analysis. 
In this population of larger chondrocytes, FACS analysis re­
vealed that only 5–7% of chondrocytes were in S phase at the ini­
tiation of alginate culture (Fig. 2E), whereas 15–20% of cells were 
in S phase in embryonic growth plate cartilage.50 However, during 
7 days of culture within the alginate hydrogel beads, we observed 
a statistically significant increase in the percentage of cells in S 
phase that approached the level reported in vivo (Fig. 2E). Since 
PTHrP has been shown to both inhibit hypertrophy and promote 
cell proliferation in cartilage,16,17 we next asked whether PTHrP 
was expressed by chondrocytes in our alginate culture. ddPCR 
analysis confirmed a significant upregulation of PTHrP expression 
over 7 days of culture (Fig. 2F). Taken together, these data sug­
gest that our minimal culture conditions are sufficient to main­
tain the growth plate chondrocyte phenotype in vitro. 
PTH1–34 treatment promotes cell proliferation in alginate 
bead culture 
Given the correlations between PTHrP expression, cell prolifera­
tion, and chondrocyte differentiation, we next asked whether the 
stimulation of PTHrP signaling could further enhance cell pro­
liferation and chondrogenesis. We cultured chondrocytes in the 
presence of recombinant human PTH1–34, a 34­amino­acid pep­
tide derived from the N­terminus of the parathyroid hormone 
that has been shown to activate the same receptor and down­
stream signal transduction pathways as the natural ligand PTHrP 
in chondrocytes.9,17 FACS analysis showed that 1 day treatment 
with PTH1–34 increased the fraction of cells in S phase as com­
pared with untreated controls, whereas no significant difference 
was observed after 4 days of treatment even when culture me­
dium and factors were replaced every day (Fig. 3A). It should be 
noted that the fraction of S­phase cells in PTH1–34 stimulated 
cultures was identical after 1 and 4 days of treatment (compare 
100 nM PTH on day 1 and 4). Therefore, the apparent desensiti­
zation to PTH1–34 treatment results from the increase in cell cy­
cle activation over time in untreated cultures (compare 0 nM PTH 
on day 1 and day 4). Thus, exogenous stimulation of PTHrP sig­
naling enhances chondrocyte cell proliferation in the short term, 
but it does not appear to have long-term benefits. 
In addition to stimulating cell cycle progression, PTH1–34 
also significantly reduced the expression of ColX (hypertrophic 
chondroctyes, Fig. 3B) and Ihh (prehypertrophic chondrocytes, 
Fig. 3C), as well as endogenous expression of PTHrP after 1 day 
of treatment as compared with control cultures (Fig. 3E). One 
Fig. 2. Culture in alginate 
hydrogel restrains cartilage 
differentiation. Gene expression 
analysis of alginate cultures 
using ddPCR (n = 4) to count 
mRNA transcripts of Collagen 
2 (A), Collagen 1 (B), Collagen 
X (D), and PTHrP (F). Values 
are reported as fold change in 
gene expression relative to day 
1. (C) Ratio of mRNA transcript 
counts of Collagen 2 and 
Collagen 1. (E) Propidium iodide 
cell cycle analysis by FACS to 
quantify percentage of cells in 
S phase (DNA synthesis for cell 
proliferation/ growth). Alginate 
cultures tend to increase the 
number of proliferating cells 
over time, compared with D0 
and D1 (n = 3). *p < 0.05, **p 
< 0.01. ddPCR, digital droplet 
polymerase chain reaction; 
FACS, fluorescence activated 
cell sorting; PTHrP, parathyroid­
related protein.   
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interesting observation was that PTH1–34 treatment continued 
to repress ColX expression after 4 days of treatment, whereas 
the expression of other genes (i.e., Ihh and PTHrP) had already 
returned to the level of untreated cultures. Therefore, we de­
cided to validate the ddPCR results by analyzing gene expres­
sion at single­cell resolution by using FISH. In situ hybridization 
in alginate beads is difficult because the elevated hybridization 
temperatures, denaturing conditions, and metal ion chelation of 
hybridization buffers promote depolymerization of the alginate 
scaffold. To address this issue, we devised a novel tissue process­
ing protocol in which alginate beads are stabilized before cryo­
embedding by infiltration with acrylamide and induction of po­
lymerization with ammonium persulfate. 
Using this method, we were able to carry out FISH on slides 
without disrupting the integrity of bead architecture, which al­
lowed the spatial relationships between cells in our culture to be 
accurately determined. We visualized gene expression in each 
cell with fluorescence microscopy (Fig. 4A, left), and quantified 
the total cell number (DAPI), as well as the number of hyper­
trophic chondrocytes (ColX) and immature chondrocytes (ColII) 
by using an object­counting macro in ImageJ (see Supplemen­
tary Data). These values were used to calculate the hypertrophic 
index (ratio of ColX­positive cells:ColII­positive cells) that de­
scribes the state of chondrocyte maturation in regions of the al­
ginate beads. Using this approach, we found that PTH1–34 treat­
ment reduced the hypertrophic index after both 1­day and 4­day 
treatments (Fig. 4B). Although the downward trend on each day 
was not statistically significant, the overall effect of PTH1–34 
treatment across days was a significant reduction in hypertro­
phic index. Thus, together, in situ hybridization image analysis 
and ddPCR transcript quantification demonstrate long-term re­
pression of ColX expression by continuous PTH1–34 treatment. 
Activation of IHH signaling induces chondrocyte hypertro-
phy in alginate bead culture 
In vivo, IHH signaling both promotes chondrocyte hypertro­
phy 8,10,15 and activates PTHrP gene expression,2,5 which an­
tagonizes chondrocyte maturation, including hypertrophy.14–17 
Therefore, we next asked which effect would dominate after ex­
ogenous activation of IHH signaling in alginate culture. To an­
swer this question, we used three known activators of IHH sig­
naling: PMA, a commonly used agonist of Smoothened, the 
signaling component of the hedgehog receptor complex51; 
thyroxine, a hormone that activates IHH expression in chon­
drocytes52,53; and BMP4, which is known to upregulate IHH ex­
pression.12,54 At all time points analyzed, IHH­activating agents 
increased the hypertrophic index, as determined by FISH analy­
sis (Fig. 5A, B) and increased the fraction of large cells as deter­
mined by FACS analysis (Supplementary Fig. S2). After pooling 
data from different time points, it was determined that overall, 
1 and 5 ng/mL BMP4, 0.5 μg/mL PMA, and 500 ng/mL thyroxine 
Fig. 3. Treatment with  
PTH1–34 accelerates the 
chondrocyte response to 
alginate bead culture. (A) 
Propidium iodide cell cycle 
analysis by FACS to quantify 
percentage of cells in S 
phase (DNA synthesis for 
cell proliferation/ growth). 
PTH treatment on day 1 
stimulates proliferation 
similar to levels that are 
typically seen in day 4 
cultures. However, 4 days 
of PTH treatment has little 
effect (n = 4). (B–E) Gene 
expression analysis was 
performed on PTH­treated 
alginate cultures with ddPCR 
to count mRNA transcripts. 
On day 1 (left), PTHrP 
signaling inhibits expression 
of Collagen X (B), IHH (C), 
and PTHrP (E), but not 
Collagen 2 (D). After 4 days 
of culture (right), the effects 
of PTHrP on gene expression 
are greatly attenuated (n 
= 3). *p < 0.05, **p < 0.01, 
and ***p < 0.001. IHH, 
Indian hedgehog; N.S., not 
significant.  
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each significantly increased the hypertrophic index of bead cul­
tures. In addition, both PMA and thyroxine maintain the propor­
tion of large (growth factor responsive) cells in alginate culture 
(Fig. 5C, D). Given that direct activation of IHH signaling by the 
Smoothened agonist PMA increased the hypertrophic index to 
a greater extent than the indirect activators thyroxine and BMP4, 
we next asked whether recombinant IHH protein could simi­
larly induce chondrocyte hypertrophy. As expected, hypertro­
phy was induced by IHH, as determined by the ColX:ColII ratio 
(Fig. 5A, B). However, the induction of hypertrophy (ColX­posi­
tive cells) was observed exclusively in cells near the bead surface, 
appearing as a ring illuminating the bead edges when analyzed 
by epifluorescence microscopy (Fig. 6A).Conversely, ColII­posi­
tive cells were enriched within core of the bead (Fig. 6A, quanti­
fication in Fig. 6B, C). Interestingly, treatment with thyroxine, but 
not PMA, also induced the formation of a peripheral ColX-ex­
pression domain (Fig.6D). These data demonstrate regionaliza­
tion of chondrocytes within alginate bead cultures into a layer 
Fig. 4. Visualizing chondrocyte gene 
expression in alginate bead culture. (A) 
Fluorescent images generated by using 
our improved protocol exploiting 
acrylamide embedding of fixed beads 
in conjunction with fluorescent in 
situ hybridization (FISH) to visualize 
cells that highly express Collagen II 
(left) and Collagen X (right) as a cell­
by­cell measure of hypertrophic 
differentiation. Images are analyzed 
via a fully automated macro in ImageJ 
to quantify the percentage of cells 
expressing each gene relative to a 
nuclear DAPI stain. Ratio of these 
percentages was calculated (ColX/
Col2) to yield a hypertrophic index 
(refer to Methods for more details). (B) 
Quantification of hypertrophic index 
in PTH1–34 treated and untreated 
cultures (n = 3). PTH1–34, parathyroid 
hormone 1–34.   
Fig. 5. Induction of hypertrophy 
after exogenous activation of 
IHH signaling. (A, B) Analysis of 
FISH derived images to calculate 
the extent of hypertrophy in 
alginate cultures treated with 
thyroxine (10, 500 ng/mL), BMP4 
(1, 5 ng/mL), PMA (0.5, 5 μg/mL), 
and IHH (100 ng/mL) for a single 
day (A) and for 4 days in culture 
(B) (n = 3). In panel B, PMA 20 
day 4, the error bar is much 
larger than the rest of the data 
points and, therefore, is clipped 
by the axis. (C, D) Propidium 
iodide analysis of stimulated 
bead cultures was performed to 
quantify the percentage of cells 
in S phase (n = 3) on days 1 (C) 
and 4 (D). *p < 0.05, **p < 0.01, 
and ***p < 0.001. BMP4, bone 
morphogenetic protein­ 4; PMA, 
purmorphamine.    
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of hypertrophic­zone­like cells on the bead periphery that sur­
rounds a core of less mature chondrocytes. To our knowledge, 
this is the first example of zonal chondrocyte organization in a 
tissue­engineered cartilage construct in vitro. 
Discussion 
In children, growth plate cartilage is crucial to skeletal morpho­
genesis. Defects in growth plate function due to genetics (inci­
dence of chondrodysplasia—1 in 5000 births), metabolic disease, 
radiation and chemotherapy, and high impact fractures affect 
skeletal growth, which can lead to deformities, growth arrest, 
or structural instability of developing long bones.22–24 However, 
an incomplete understanding of the molecular and cellular pro­
cesses that produce growth has resulted in few clinical options 
to treat growth defects and has severely limited advances in tis­
sue engineering and regenerative strategies to replace damaged 
or diseased tissue.22–24 Although genetic models have identified 
many important molecules that regulate cartilage morphogen­
esis, a deeper mechanistic understanding of growth regulation 
in vertebrates has been confounded by the lack of tools for pre­
cise and combinatorial genetic manipulation that is needed to 
determine mechanism. In vitro models offer the potential to si­
multaneously regulate multiple secreted, matrix, and mechani­
cal factors in space and time.55–58 Here, we describe the devel­
opment of a 3D chondrocyte culture system by using mouse 
neonatal growth plate chondrocytes encapsulated in an alginate 
hydrogel to investigate the mechanisms underlying growth plate 
formation, regulation, and growth disorders. 
3D alginate culture favors immature chondrocytes 
For many tissues, two-dimensional cultures are sufficient to pre­
serve cell phenotypes and cell-specific responses to growth fac­
tor signaling. However, in the case of growth plate cartilage, 
monolayer cultures promote dedifferentiation of chondrocytes, 
abnormal gene expression profiles, and inappropriate responses 
to signaling factors.59–62 The 3D culture of chondrocytes in pel­
lets, micromass, or artificial scaffolds has been shown to main­
tain the chondrogenic phenotype.27–31,61,62 Although pellet 
cultures have been induced to generate a growth plate­like ar­
chitecture, the difficulty of manipulating these cultures to gener­
ate regional differences in signaling factor concentrations or ma­
trix composition inspired us to explore culture models in which 
Fig. 6. IHH treatment in alginate 
bead culture is sufficient to 
establish chondrocyte zonal 
arrangement. (A) FISH (top) was 
used to visualize ColX­expressing 
(left) and ColII­expressing (right) 
cells in 100 ng/mL IHH­treated 
cultures. White dotted lines 
delineate the observed zones 
of predominant expression. Red 
dotted lines delineate the outer 
boundary of the bead. Beads 
form a ColX­enriched ring (outer 
portion) surrounding a ColII­
enriched core (inner portion). 
DAPI (middle) is shown on the 
right to demonstrate that cells 
are still evenly dispersed in 
hydrogel culture after 4 days, 
aside from isogenic groups, 
(n = 3). (B) Counts of ColII­
expressing and ColX­expressing 
cells (divided by the count of 
DAPI­positive nuclei in each 
FISH image), stacked in a bar 
graph to illustrate the relative 
predominance of hypertrophic 
versus nonhypertrophic 
chondrocytes in different 
domains of the IHH­treated 
alginate beads. (C) Hypertrophic 
indexes of different domains of 
the IHH treated alginate beads. 
(D) FISH was used to visualize 
ColX­expressing (left) and total 
(right) chondrocytes in alginate 
cultures treated with 10 ng/mL 
thyroxine.   
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chondrocytes are encapsulated in hydrogel scaffolds that have 
defined composition. The choice of scaffold is potentially impor­
tant, since a physical interaction of scaffold materials with cells 
and growth factors might significantly alter outcomes of these 
models. Therefore, we chose alginate as a scaffold material be­
cause the low cell adhesion, limited protein binding, and min­
imal cell toxicity of this material render alginate a ‘‘blank slate’’ 
for the introduction of defined signaling and matrix factors. The 
many advantages of alginate also include mild gelation condi­
tions, fluid diffusion of nutrients and wastes into and out of the 
construct, and accessible functional groups for modifications.39 
For these reasons, many cell types, including articular chondro­
cytes,28 have been successfully cultured in alginate gels. 
Our basal culture conditions display high viability and ex­
tracellular matrix deposition that are consistent with previous 
reports,27 which suggests that the basal culture conditions are 
permissive for chondrogenesis. However, unlike previously de­
scribed growth plate cartilage cultures, we observed a rapid 
and significant decrease in chondrocyte hypertrophy and a con­
comitant increase in cell proliferation during 7 days in culture. 
These findings are important because the induction of hyper­
trophy and cell cycle exit are common observations in mono­
layer and micromass culture of chondrocytes.25,26 In these con­
texts, hypertrophy is often accompanied by expression of IHH 
and BMPs, and, thus, it has been assumed that isolated growth 
plate chondrocytes are unable to maintain expression of factors 
that are required to repress chondrocyte maturation.54 By con­
trast, our results demonstrate that these alginate culture condi­
tions promote the maintenance of proliferating and growth fac­
tor­responsive chondrocytes that exhibit minimal hypertrophy. 
Although the mechanism remains to be defined, endogenous 
production of PTHrP might underlie preservation of the chon­
drocyte phenotype in alginate since PTHrP expression continued 
to increase during the 7 day culture period and the addition of 
exogenous PTH1–34 inhibited the expression of both ColX and 
IHH, transcriptional markers of chondrocyte hypertrophy. These 
data strongly suggest that resting/proliferative chondrocytes, 
not hypertrophic chondrocytes, are the default maturation state 
in our alginate cultures. 
PTHrP signaling is the primary driver of  
cell proliferation in alginate culture 
Although endogenous PTHrP production likely plays an impor­
tant role in the maintenance of chondrogenesis, PTHrP expres­
sion in our culture system increases at a rate that is probably 
suboptimal for chondrocyte cultures. For example, during 7 days 
in basal medium, our cultures display increased cell cycle entry 
from ~5% of cells in S phase at day 0 to ~15% by day 7. In con­
trast, ~20% of resting and proliferative chondrocytes are in S 
phase in embryonic growth plate cartilage.50 However, after only 
1 day of treatment with PTH1–34, cell proliferation within our 
cultures was restored to in vivo levels in our cultures. PTH1–34 
stimulation of cell proliferation occurs concomitant with a loss 
of IHH expression, suggesting that PTHrP signaling alone is the 
primary driver of cell proliferation in these cultures. 
The apparent primacy of PTHrP signaling is surprising given 
the genetic evidence for roles of IHH,Wnt5a, and Wnt5b in cell 
cycle control.12,20,50 This paradox could be explained if these 
growth factors regulate PTHrP expression or if PTH1– 34 induces 
the expression of additional endogenous growth factors. The in 
vivo observation of 20% S phase cells likely represents a limit to 
the rate of proliferation in heterogeneous chondrocyte popula­
tions, since this rate was not exceeded by using lower or higher 
concentrations of PTH1­34 (data not shown). Together, our data 
suggest that the establishment of PTHrP signaling is a crucial 
step to restore normal cell proliferation levels in growth plate 
chondrocyte cultures. However, one potential challenge to us­
ing PTH1–34 in long­term cultures is the potential for desensi­
tization of the PTHrP signaling pathway (Fig. 3), which could al­
ter the cell proliferation rate and possibly lead to the induction 
of cell hypertrophy. Results presented here suggest that chronic 
treatment is not detrimental to cultures since continuous stimu­
lation with PTH1–34 maintained maximum levels of cell prolifer­
ation and minimum levels of ColX and Ihh expression for at least 
7 days in our cultures. Given these results, we suggest that PTHrP 
signaling plays a crucial, yet underappreciated role in maintain­
ing cultures of growth plate chondrocytes. 
IHH signaling establishes a hypertrophic zone  
in alginate culture 
PTH1–34 stimulation of the cell cycle and repression of hypertro­
phy (Fig. 3A, B) demonstrate that PTHrP pathway functions are 
maintained in chondrocytes within our alginate cultures.3,6 Like­
wise, our data show that functions of the IHH signaling pathway 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Model exploring the potential mechanisms of IHH­driven zonal 
demarcation. Possibilities include an outside-in IHH-diffusion gradient 
(left) where cells that are exposed to high levels of IHH are induced to 
hypertrophy, but at the center of the bead, cells are seeing less IHH and 
maintain a static differentiation state. Alternatively, IHH diffuses into the 
bead rapidly, creating a uniform IHH concentration in media (right). Un­
der this model, IHH induction of hypertrophy is balanced by endogenous 
PTHrP expression (differentiation block). Since PTHrP rapidly diffuses out 
of alginate but is constantly produced, this forms a radial gradient of 
PTHrP from the inside out where cells on the outer ring are exposed to 
a higher IHH/ PTHrP ratio, causing induction of hypertrophy.   
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are also preserved in these cultures. Specifically, the activation of 
IHH signaling either directly (IHH or PMA) or indirectly via BMP 
signaling (thyroxine or BMP4) increased the proportion of ColX­
expressing chondrocytes in bead cultures (Fig. 5A, B). Induction 
of chondrocyte hypertrophy is an important PTHrP­independent 
function of IHH in vivo.8 Thus, in combination with the data from 
PTH1–34 treatments, our results demonstrate preservation in al­
ginate culture of the crucial functions that comprise the PTHrP­
IHH signaling feedback loop, a key node in the regulatory net­
work of growth plate cartilage.2,5 
Although treatment with IHH, PMA, or thyroxine resulted in 
similar effects on chondrocyte hypertrophy, we observed one 
crucial difference—both IHH and thryoxine treatments pro­
duced regional differences in chondrocyte hypertrophy in al­
ginate beads. Specifically, treatment with IHH or thyroxine was 
sufficient to stratify alginate bead cultures into an inner core 
consisting of nonhypertrophic (resting/proliferative) chondro­
cytes and an outer ring of ColX­expressing hypertrophic chon­
drocytes, which mimics the layered organization of growth plate 
cartilage in vivo. 
Regional differences were unexpected from treatment with a 
single factor, but they could occur if diffusion of the hypertro­
phy­inducing factors into the bead was rate limiting. Restricted 
diffusion of IHH might be expected since the pore size in 1.5% 
alginate gels restricts the diffusion of molecules in the 10–70 kD 
range to varying degrees37 and mature IHH protein has a mo­
lecular mass of 20 kD. However, IHH is sufficiently small that it 
could be expected to equilibrate in concentration throughout 
the bead during 4 days in culture,37 and, therefore, a distinction 
between the core and the periphery should lessen over time. An 
additional argument against a requirement for sustained exog­
enous concentration gradients is the observation that the small 
molecule thyroxine also induced a hypertrophic domain. Thy­
roxine has a negative charge that should limit interaction with 
the alginate scaffold and a low molecular weight (0.78 kD) that 
should allow unimpeded diffusion in alginate gels.52 Therefore, 
the current data do not support a model in which sustained con­
centration gradients of signaling molecules are required to es­
tablish zonal differences in growth plate chondrocytes. 
If not by sustained concentration gradients of exogenous sig­
naling molecules, what mechanism might account for regional­
ization of chondrocytes in alginate beads? An alternative model 
is that a concentration gradient is only transiently required to ini­
tiate the formation of distinct maturation domains. In this con­
text, the current results most likely indicate induction of PTHrP 
expression in the nonhypertrophic core chondrocytes in re­
sponse to IHH produced by the peripheral hypertrophic chon­
drocytes (Fig. 7). In turn, endogenously produced PTHrP from the 
core chondrocytes might diffuse toward the periphery, inhibiting 
IHH-dependent hypertrophy. Consequently, an initial anisotropic 
growth factor stimulus can activate the endogenous IHHPTHrP 
signaling feedback interaction that generates distinct zones of 
chondrocyte maturation as observed in vivo. 
Conclusion 
Our results are the first demonstration of a tunable, 3D cul­
ture model of growth plate cartilage. This culture system will be 
an important tool for elucidating the mechanisms underlying 
chondrocyte differentiation, cartilage architecture. In addition, 
our in vitro model could be used to advance drug discovery by 
facilitating high­throughput screening for molecules that regu­
late cartilage growth. Finally, our results encourage future stud­
ies that aim at using alginate hydrogel scaffolds to engineer car­
tilage constructs of defined proportions in vitro.     
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Supplementary Data
Supplementary ImageJ Macro
title = getTitle;
dotIndex = indexOf(title, ‘‘.’’);
Name = substring(title, 0, dotIndex);
run(‘‘Stack to Images’’);
selectWindow(Name+’’–0001’’);
setOption(‘‘BlackBackground’’, false);
run(‘‘Make Binary’’, ‘‘thresholded remaining black’’);
run(‘‘Analyze Particles.’’, ‘‘size = 50–1000 clear sum-
marize’’);
selectWindow(Name+’’–0002’’);
setOption(‘‘BlackBackground’’, false);
run(‘‘Make Binary’’, ‘‘thresholded remaining black’’);
run(‘‘Analyze Particles.’’, ‘‘size = 50–1000 clear sum-
marize’’);
selectWindow(Name+’’–0003’’);
setOption(‘‘BlackBackground’’, false);
run(‘‘Make Binary’’, ‘‘thresholded remaining black’’);
run(‘‘Analyze Particles.’’, ‘‘size = 50–1000 clear sum-
marize’’);
selectWindow(Name+’’–0004’’);
setOption(‘‘BlackBackground’’, false);
run(‘‘Make Binary’’, ‘‘thresholded remaining black’’);
run(‘‘Analyze Particles.’’, ‘‘size = 50–1000 clear sum-
marize’’);
selectWindow(Name+’’–0005’’);
setOption(‘‘BlackBackground’’, false);
run(‘‘Make Binary’’, ‘‘thresholded remaining black’’);
run(‘‘Analyze Particles.’’, ‘‘size = 50–1000 clear sum-
marize’’);
selectWindow(Name+’’–0006’’);
setOption(‘‘BlackBackground’’, false);
run(‘‘Make Binary’’, ‘‘thresholded remaining black’’);
run(‘‘Analyze Particles.’’, ‘‘size = 50–1000 clear sum-
marize’’);
close(‘‘*’’)
Supplementary Table S1. Sequence of Primers Used for Digital Droplet Polymerase
Chain Reaction Amplification
Gene Forward sequence Reverse sequence
Actin NM_007393.342–44 AAATCGTGCGTGACATCAAAGA GCCATCTCCTGCTCGAAGTC
HPRT NM_013556.242–44 GACCTCTCGAAGTGTTGGATAC TCAACAGGACTCGTATTTG
RPL13-a NM_009438.445 ATCCCTCCACCCTATGACAA GCCCCAGGTAAGCAAACTT
Col1 NM_007742.446 GCAACAGTCGCTTCACCTAC GTGGGAGGGAACCAGATTG
Col2 NM_03116347 CGAGTGGAAGAGCGGAGACTAC CCAGTTTTTCCGAGGGACAGT
ColX NM_00992546 TTCTGCTGCTAATGTTCTTGACC GGGATGAAGTATTGTGTCTTGGG
PTHrP NM_008970 GAAACGCAGAGAACAGGAGAA AATTTCAATGCGTCCTTAAGCTG
IHH NM_01054448 CCCCAACTACAATCCCGACA TCATGAGGCGGTCGG
Primers used for ddPCR gene expression analysis. The table lists provided earlier give the name of all genes analyzed by ddPCR in the
current study, the gene accession numbers that were used to generate each set of primers, and the publications that guided the selection of
primers, where applicable (left column). Full sequences for each primer used in the current study (forward and reverse) are shown to the
right.
ddPCR, digital droplet polymerase chain reaction; IHH, Indian hedgehog.
Supplementary Table S2. Quantification of the Live-Dead Stains from Figure 1A
Time point Live count Dead count Total cells Live/total Percent viability
Day 0 100 9 109 0.92 92
Day 1 143 11 154 0.93 93
Day 4 314 10 324 0.97 97
Day 7 258 13 271 0.95 95
Fluorescence images resulting from our viability assay were input to our automated ImageJ object-counting macro. Results from all time
points analyzed are shown in each row. Counts in the green channel (live cells) and red channel (dead cells) were summed to calculate total
cells. The ratio of living and total cells was multiplied by 100 to calculate percent viability (rightmost column).
SUPPLEMENTARY FIG. S1. Two distinct populations of chondrocytes isolated from growth plate cartilage and cul-
tured alginate beads. (A, B) Examples of scatterplots generated in ModFit LTE software showing distributions of cell area
with respect to cell width (left) and forward scatter with respect to side scatter (right) of propidium iodide-stained
chondrocytes isolated from alginate bead culture. Rectangles show the gating strategy used to separate FACS data per-
taining to smaller (A) versus larger (B) chondrocytes. *p< 0.05.
SUPPLEMENTARY FIG. S2. Cell size distribution modulated by exogenously activating IHH signaling. For all panels,
counts of large, small, and total cell populations derived from propidium iodide S-phase analysis and used to calculate the
fraction of total cells that were in the larger cell population. (A) Large cell fraction of chondrocytes cultured for 1 (left) and
4 (right) days in the presence or absence of PTH1–34 or IHH (n = 3). (B, C) Large cell fraction of chondrocytes cultured in
the presence or absence of IHH-stimulating factors for 1 day (B) and 4 days (C) in culture. BMP4, bone morphogenetic
protein-4; IHH, Indian hedgehog; PMA, purmorphamine; PTH1-34, parathyroid hormone 1–34. For all graphs, *p < 0.05.
